Начало › Метастатичен рак › Мичиган › Grand Rapids
Клинични проучвания за Метастатичен рак в Grand Rapids, MI
22 проучвания за Метастатичен рак търсят участници в обекти в и около Grand Rapids (в радиус от около 30 мили). Отворете проучването, за да видите кой може да участва и как да се свържете с екипа.
Официален текст на проучването (английски)
Търсите участници за проучване? Представяме го в началото на тази страница — $99 за 30 дни →
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
Набиране на участнициФаза 2
- Corewell Health Grand Rapids Hospitals - Butterworth Hospital, Grand Rapids
- Trinity Health Grand Rapids Hospital, Grand Rapids
A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors
Набиране на участнициФаза 1
- South Texas Accelerated Research Therapeutics (START), Grand Rapids
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
Набиране на участнициФаза 1
- START Midwest Cancer and Hematology Centers of W Michigan, Grand Rapids
A Study to Assess the Safety, Tolerability, Pharmacokinetic, Pharmacodynamic, Immunogenicity and Antitumour Activity of IPN60300 in Adults With Locally Advanced or Metastatic Solid Tumours
Набиране на участнициФаза 1/2
- START Midwest, Grand Rapids
A First in Human Study of ALX2004 With Advanced or Metastatic Selected Solid Tumors
Набиране на участнициФаза 1
- ALX Center 3, Grand Rapids
Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors
Набиране на участнициФаза 2/3
- The Cancer and Hematology Centers, Grand Rapids
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
Набиране на участнициФаза 3
- The Cancer & Hematology Centers, Grand Rapids
- The Cancer & Hematology Centers, Grand Rapids
A Study of LY4257496 in Participants With Cancer (OMNIRAY)
Набиране на участнициФаза 1
- BAMF Health Inc., Grand Rapids
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
Набиране на участнициФаза 1/2
- START Midwest, Grand Rapids
Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer
Набиране на участнициФаза 1/2
- START Midwest, Grand Rapids
CR-001 in Adult Participants With Locally Advanced or Metastatic Solid Tumors
Набиране на участнициФаза 1/2
- Clinical Study Site, Grand Rapids
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
Набиране на участнициФаза 3
- The Cancer & Hematology Centers, Grand Rapids
A Study to Assess the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, Immunogenicity and Anti-tumour Activity of IPN01203 in Adults With Locally Advanced or Metastatic Solid Tumours Exposed to Immune Checkpoint Inhibitor Therapies
Набиране на участнициФаза 1/2
- South Texas Accelerated Research Therapeutics (START) - Midwest, Grand Rapids
A Study With NKT5097 for Adults With Advanced/Metastatic Solid Tumors
Набиране на участнициФаза 1
- South Texas Accelerated Research Therapeutics (START) Midwest, Grand Rapids
A Study of MGC026 in Participants With Advanced Solid Tumors
Набиране на участнициФаза 1
- START Midwest, Grand Rapids
A Study of mRNA-4106 or mRNA-4200 Administered Alone or in Combination With Anti-Cancer Agents in Participants With Solid Tumors
Набиране на участнициФаза 1
- START Midwest, Grand Rapids
A Study to Investigate Safety and Effectiveness of CRN09682 in Participants With SST2-Expressing NENs and Other Solid Tumors
Набиране на участнициФаза 1/2
- Crinetics Study Site, Grand Rapids
CT-95 in Advanced Cancers Associated With Mesothelin Expression
Набиране на участнициФаза 1
- Context Investigational Site, Grand Rapids
A Study to Find a Suitable Dose of ASP5834 in Adults With Solid Tumors
Набиране на участнициФаза 1
- START Midwest, Grand Rapids
A First-In Human (FIH) Study to Find Out How Well REGN10597 Medicine Given Alone or in Combination With Cemiplimab Works in Adult Participants Who Have Cancer With Tumors That Have Spread in Their Body
Набиране на участнициФаза 1/2
- Start Midwest Cancer Research, Grand Rapids
Collection and Storage of Tissue and Blood Samples From Patients With Cancer
Набиране на участнициНаблюдателно проучване
- Corewell Health Grand Rapids Hospitals - Butterworth Hospital, Grand Rapids
Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors
Набиране на участнициФаза 1/2
- START Midwest, Grand Rapids
Проучвания за Метастатичен рак в други градове
- Houston, TX104 проучвания
- New York City, NY93 проучвания
- Nashville, TN70 проучвания
- Boston, MA63 проучвания
- Los Angeles, CA57 проучвания
- St. Louis, MO54 проучвания
- Arlington, VA53 проучвания
- Philadelphia, PA46 проучвания
- Chicago, IL45 проучвания
- San Antonio, TX44 проучвания
- Washington, DC43 проучвания
- Dallas, TX42 проучвания
Други проучвания в Grand Rapids
- Рак на белия дроб с недребноклетъчен тип44 проучвания
- Колоректален рак40 проучвания
- Рак (всички видове)28 проучвания
- Рак на гърдата26 проучвания
- Рак на яйчниците24 проучвания
- Рак на простатата19 проучвания
- Рак на панкреаса18 проучвания
- Рак на стомаха18 проучвания
- Ендометриален рак18 проучвания
- Меланом17 проучвания
- Тройно негативен рак на гърдата15 проучвания
- Плоскоклетъчен карцином на главата и шията15 проучвания
От ClinicalTrials.gov, данни към 7.10.2026 г.. Всяко проучване има свои критерии за участие; екипът на проучването определя кой може да се включи.